Alexander Weber, MD
Sports Medicine · Los Angeles, CANPI 1366763138
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $64,775 of the $81,766 with a category attached, or 79.2%. Stryker accounts for 88.5% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2024 at $17,893 and has fallen 52.0% since, to $8,593 in 2025. Among sports medicine clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 107 payments — averaging $764.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$72K
- Arthrex$9K
- Pinnacle, Inc$218
- Boston Scientific$165
- Smith+Nephew$165
- Saxum Surgical, Inc.$135
- plus $158 from 3 others
What the payments were for
- Consulting fees$64,77579%
- Speaking & faculty fees$8,00010%
- Travel & lodging$4,2035%
- Food & beverage$4,7886%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 92 | $72,332 |
| Arthrex | 4 | $8,593 |
| Pinnacle, Inc | 2 | $218 |
| Boston Scientific | 2 | $165 |
| Smith+Nephew | 3 | $165 |
| Saxum Surgical, Inc. | 1 | $135 |
| DJO, LLC | 1 | $94 |
| Micromed Inc | 1 | $40 |
| Vericel Corporation | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$81,766 in reported general payments places this provider in the 90th percentile of 662 sports medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 41 | $71 |
| Tramadol Hcl | 12 | $22 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Los Angeles
- Neal ElattracheLos Angeles$51M
- Carleton VangsnessLos Angeles$872K
- Michael BanffyLos Angeles$578K
- Seth GamradtLos Angeles$567K
- Reza OmidLos Angeles$400K
- Orr LimpisvastiLos Angeles$335K
- George HatchLos Angeles$255K
- David McAllisterLos Angeles$186K
- James TiboneLos Angeles$74K
- Carlos UquillasLos Angeles$68K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.